Health experts say that "skinny jabs" should also be avoided when trying to get pregnant or while breastfeeding ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

The NHS Mounjaro rollout begins next week across the UK, and here are the side effects users need to be aware of ...

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

Some Ozempic users have reported severe gastrointestinal side effects like stomach paralysis and uncontrollable vomiting.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Dr. Andrea D. Sullivan urges Americans to rethink the Ozempic craze and address the root cause: a lack of education about food and lifestyle. The real epidemic is our disconnection from food—what we ...

Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...